Back to Diagnostics & Biomarkers
Diagnostics & Biomarkers

Continuous Glucose MonitorEvidence & Dosage

Real-time blood glucose via sensor — the learning curve and limitations.

Studies last updated

Evidence at a glance

Total studies
1,000
With abstract
48
Meta / Systematic / RCT
158
Highly cited
50
Publication years
2001–2026

Continuous Glucose Monitor in the context of Diagnostics & Biomarkers

This topic is part of our "Diagnostics & Biomarkers" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Diagnostics & Biomarkers

Top studies on Continuous Glucose Monitor

Ranked by influential-citation count and publication year.

  1. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.

    Diabetologia2024Meta-Analysis200 influential citations

    <h4>Aims/hypothesis</h4>Continuous glucose monitoring (CGM) is increasingly used in the treatment of type 2 diabetes, but the effects on glycaemic control are unclear. The aim of this systematic review and meta-analysis is to provide a…

  2. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.

    Diabetes Care2024Meta-Analysis187 influential citations

    <h4>Background</h4>Traditional diabetes self-monitoring of blood glucose (SMBG) involves inconvenient finger pricks. Continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems offer CGM, enhancing type 2 diabetes…

  3. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.

    Diabetes Care2020Meta-Analysis171 influential citations

    BACKGROUND Continuous glucose monitoring (CGM) provides important information to aid in achieving glycemic targets in people with diabetes. PURPOSE We performed a meta-analysis of randomized controlled trials (RCTs) comparing CGM with…

  4. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.

    Lancet Diabetes Endocrinol2017n=585Meta-Analysis162 influential citations

    <h4>Background</h4>Closed-loop artificial pancreas systems have been in development for several years, including assessment in numerous varied outpatient clinical trials. We aimed to summarise the efficacy and safety of artificial pancreas…

  5. Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    Diabetes Technol Ther2024Meta-Analysis126 influential citations

    <b><i>Introduction:</i></b> Continuous glucose monitoring (CGM) has shown favorable outcomes in patients with type 2 diabetes (T2D) who are on insulin therapy. However, the efficacy of CGM in managing glucose levels in noninsulin-treated…

  6. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

    Ann Intern Med2012n=33Meta-Analysis119 influential citations

    <h4>Background</h4>Patients with diabetes mellitus need information about the effectiveness of innovations in insulin delivery and glucose monitoring.<h4>Purpose</h4>To review how intensive insulin therapy (multiple daily injections [MDI]…

  7. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

    J Clin Endocrinol Metab2024n=14meta115 influential citations

    PURPOSE: To provide a systematic review and meta-analysis synthesizing the findings of randomized controlled trials (RCTs) of continuous glucose monitors (CGMs) in the management of adults with type 2 diabetes mellitus (T2DM) on glucose…

  8. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.

    Diabetologia2022Meta-Analysis112 influential citations

    <h4>Aims/hypothesis</h4>The aim of this work was to assess the effectiveness of continuous glucose monitoring (CGM) vs self-monitoring of blood glucose (SMBG) in maintaining glycaemic control among people with type 1 diabetes…

  9. Use of continuous glucose monitoring and point-of-care glucose testing in hospitalized patients with diabetes mellitus in non-intensive care unit settings: A systematic review and meta-analysis of randomized controlled trials.

    Diabetes Res Clin Pract2025n=979Meta-Analysis87 influential citations

    The benefits of using continuous glucose monitoring (CGM) in hospitalized patients with diabetes remain uncertain. Point-of-care (POC) glucose testing is the standard of care in this setting. We compared the effect of adding CGM to POC…

  10. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials.

    Diabet Med2022Meta-Analysis77 influential citations

    Aims This systematic review aims to evaluate the effect of continuous glucose monitoring (CGM) on maternal and neonatal outcomes in gestational diabetes mellitus (GDM). Methods Two authors conducted a systematic search using PubMed,…

Frequently asked

Are there safety considerations for Continuous Glucose Monitor?
• Few studies reported adverse events. • Few studies reported emergency department use or hospitalization.

Related articles

More topics in Diagnostics & Biomarkers

Blood Glucose

Fasting, postprandial, glucose swings — the basis of metabolic health.

Blood Pressure Tracking

Home measurement, 24h monitoring, white-coat hypertension.

Body Temperature Tracking

Basal temperature, cycle, illness, sleep stages via wearable.

Complete Blood Count

Complete and differential blood count, red cells, white cells, platelets — the standard panel.

Cycle Tracking

Menstrual cycle, symptoms, fertility — apps and wearables.

Fasting Insulin & HOMA-IR

Detect insulin resistance early — more telling than HbA1c in at-risk patients.

Geroscience Biomarkers

Automatisch via Trend Scout entdeckt. Aging biomarkers and biological clocks are central to longevity interventions and geroscience research.. PubMed: 479 Ergebnisse.

HbA1c

A 3-month average of blood sugar, diabetes risk, a longevity marker.

Homocysteine

Methylation marker, cardiovascular and neurological risk.

HRV Tracking

Heart rate variability as a resilience and recovery indicator.

Inflammation Markers

hs-CRP, IL-6, fibrinogen — chronic low-grade inflammation as a risk factor.

Kidney Values

Creatinine, urea, eGFR, cystatin C — assessing kidney function.

Lipid Profile

LDL-C, HDL, triglycerides, ApoB — modern cardiovascular risk assessment.

Liver Values

ALT, AST, GGT, bilirubin — what high values mean and when they're a problem.

Mood Tracking

Daily mood logging, correlations with sleep/exercise/nutrition.

Nutrition Tracking

Cronometer, MyFitnessPal, macros & micros, limitations.

Resting Heart Rate

A trend marker for cardiovascular fitness and overtraining.

Thyroid Panel

TSH, fT3, fT4, plus reverse T3 and antibodies where indicated — full thyroid panel.

VO2max

Maximal oxygen uptake — the strongest longevity predictor.

Wearables

Overview: Oura, Whoop, Apple Watch, Garmin, Fitbit — pros and cons.

Related topics from other worlds